Skip to main content
. 2020 Sep 24;21(15):1065–1072. doi: 10.2217/pgs-2020-0065

Figure 1. . Boxplots depicting CYP2D6 metabolizer phenotype versus Abnormal Involuntary Movement Scale score for the (A) CAUS sample and (B) pharmacogenomic sample.

Figure 1. 

AIMS: Abnormal Involuntary Movement Scale; EM: Extensive metabolizer; IM: Intermediate metabolizer; PM: Poor metabolizer; UM: Ultra-rapid metabolizer.